This impactful program brings together early career investigators with established leaders in cancer immunotherapy to foster leadership development, collaborations and scientific exchange.
Participants must submit a completed application through Proposal Central by Thursday, Nov. 12, 2026, at 12 p.m. PT/2 p.m. CT/3 p.m. ET. This program is intended for early-career scientists and physicians (PhD and/or MD) who expect to transition to an independent position in academia, government, or industry within the next 1-2 years. Individuals from diverse scientific backgrounds are encouraged to apply.